SVCP
IBB icon

Silicon Valley Capital Partners’s iShares Biotechnology ETF IBB Stock Holding History

Silicon Valley Capital Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-70
Closed -$8.6K – 370
2023
Q3 		$8.6K Sell
70
-1
-1% -$127 ﹤0.01% 210
2023
Q2 		$9.02K Hold
71
– – ﹤0.01% 213
2023
Q1 		$9.17K Hold
71
– – ﹤0.01% 170
2022
Q4 		$9.32K Buy
+71
New +$9.18K ﹤0.01% 146

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Silicon Valley Capital Partners's IBB Position: Q4 2023 in Review

Silicon Valley Capital Partners sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 70 shares — an estimated $8.6K sold.

Silicon Valley Capital Partners first reported a position in IBB in Q4 2022 and held it in 4 quarters. The position peaked at $9.32K in Q4 2022. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • Silicon Valley Capital Partners reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • Silicon Valley Capital Partners sold 70 iShares Biotechnology ETF shares in Q4 2023, an estimated $8.6K.
  • Silicon Valley Capital Partners first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 4 quarters.
  • Silicon Valley Capital Partners's iShares Biotechnology ETF position peaked at $9.32K in Q4 2022.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Silicon Valley Capital Partners's 13F filing for Q4 2023, filed 14 Feb 2024.